Skip Navigation


NDT Advance Access originally published online on March 6, 2008
Nephrology Dialysis Transplantation 2008 23(7):2123-2126; doi:10.1093/ndt/gfn096
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/7/2123    most recent
gfn096v2
gfn096v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Haag-Weber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haag-Weber, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


The impact of residual renal function on survival

Marianne Haag-Weber

Division of Nephrology, Hospital Straubing, Germany

Correspondence and offprint requests to: Marianne Haag-Weber, Klinikum Straubing, St Elisabeth-Str. 23, D-94315 Straubing, Germany. Tel: +49-9421-782633; Fax: +49-9421-782646; E-mail: marianne.haag-weber@kfh-dialyse.de

Keywords: haemodialysis; mortality; peritoneal dialysis; residual renal function

The first 150 words of the full text of this article appear below.

Dialysis patients have 10–20 higher mortality rates compared to controls. Factors discussed to influence mortality in dialysis patients are hypertension, left ventricular hypertrophy (LVH), increased pulse pressure, phosphorus, calcification, inflammation, malnutrition, fluid and sodium balance, interdialytic weight gain, removal of middle molecule uraemic toxins and residual renal function (RRF) [1]. LVH and hypertension are frequent findings in dialysis patients and the presence of LVH has been confirmed to be an important independent determinant of survival in dialysis patients [2]. One main goal is therefore to prevent LVH and control hypertension. Whereas the role of RRF for survival is well recognized in the peritoneal dialysis population, RRF is not currently emphasized in haemodialysis (HD) patients [3,4]. At the moment there exist two strategies for HD patients: (1) control of hypertension mainly by volume control with no or few antihypertensive drugs at the expense of early . . . [Full Text of this Article]



   Residual renal function and uraemic toxicity profile
 


   Residual renal function in relation to volume state/hypertension and cardiac hypertrophy
 


   Residual renal function and survival
 


   How to control hypertension in dialysis patients
 


   Conclusion
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?